Metformin-associated hepatotoxicity;Hepatotoxicidad por metformina

Medicina Intensiva

Volumn 34, Issue 7, 2010, Pages 483-487

  Olivera Gonzalez S ^a   de Escalante Yanguela B ^a   Velilla Soriano, C ^a   Amores Arriaga, B ^a   Martin Fortea P ^a   Navarro Aguilar, M E ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Hepatotoxicity; Idiosyncratic; Metformin

Indexed keywords

ACENOCOUMAROL; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; INSULIN GLARGINE; LACTATE DEHYDROGENASE; METFORMIN; POTASSIUM; REPAGLINIDE; SODIUM; UREA;

ABDOMINAL PAIN; AGED; ANOREXIA; ARTICLE; ASTHENIA; BLOOD ANALYSIS; CASE REPORT; CLINICAL EXAMINATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; FEMALE; GASTROINTESTINAL SYMPTOM; HEART FAILURE; HEMODIAFILTRATION; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; KIDNEY DISEASE; KIDNEY FAILURE; LACTIC ACIDOSIS; LIVER BIOPSY; LIVER DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYDIPSIA; POLYURIA;

AGED; DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN;

EID: 77956918950     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2009.10.006     Document Type: Article

References (18)

1. Solano M., González C., Álvarez M., Llorente B., Echegaray M. Acidosis láctica en paciente diabético tratado con metformina. An Med Interna 2004, 21:288-290.
2. Canabal J.M., Kramer D.J. Management of sepsis in patients with liver failure. Curr Opin Crit Care 2008, 14:189-197.
3. Seeto R.K., Fenn B., Rockey D.C. Ischemic hepatitis: Clinical presentation and pathogenesis. Am J Med 2000, 109:109-113.
4. Navarro V.J., Senior J.R. Drug-related hepatotoxicity. New Engl J Med 2006, 354:731-739.
5. Cubuken A., Yilmaz M.T., Satman I. Metformin kullanimina bagli bir akupt hepatit vakasi (metformin-induced hepatitis). Tip Fak Mecm 1991, 54:447-452.
6. Babich M.M., Shiffman M.L. Metformin-induced acute hepatitis. Am J Med 1998, 104:490-492.
7. Nammour F.E., Fayad N.F., Peikin S.R. Metformin-induced cholestasic hepatitis. Endocr Pract 2003, 9:307-309.
8. Desilets D.J., Shorr A.F., Moran K.A., Holtzmuller K.C. Cholestasic jaundice associated with the use of metformin. Am J Gastroenterol 2001, 96:2257-2258.
9. De la Poza-Gómez G., Rivero Fernández M., Vázquez Romero M., Angueira Lapeña T., Arranz de la Mata G., Boixeda de Miquel D. Constitutional syndrome associated to metformin induced hepatotoxicity. Gastroenterol Hepatol 2008, 31:643-645.
10. Kutoh E. Possible metformin-induced hepatotoxicity. Am J Geriatr Pharmacother 2005, 3:270-273.
11. Deutsch M., Kounturas D., Dourakis S.P. Metformin hepatotoxicity. Ann Intern Med 2004, 140:W25.
12. Naranjo C.A., Busto U., Sellers E.M., Sandor P., Ruiz I., Roberts E.A., et al. A method for estimating the probability of adverse drug reactions. J Clin Pharmacol Ther 1981, 30:239-245.
13. María V.A., Victorino R.M. Development and validation of a clinical for the diagnosis of drug-induced hepatitis. Hepatology 1997, 26:664-669.
14. Andrade R.J., Robles M., Fernández-Castañer A., López-Ortega S., López-Vega M.C., Lucena M.I. Assessment of drug-induced hepatotoxicity in clinical practice: A challenge for gastroenterologists. World J Gastroenterol 2007, 13:329-340.
15. Danan G., Benichou C. Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. J Clin Epidemiol 1993, 46:1323-1330.
16. Benichou C., Danan G., Flahault A. Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge. J Clin Epidemiol 1993, 46:1331-1336.
17. García-Cortés M., Lucena M.I., Pachkoria K., Borraz Y., Hidalgo R., Andrade R.J. Evaluation of Naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury. Aliment Pharmacol Ther 2008, 27:780-789. Spanish Group for the Study of Drug-induced Liver Disease (grupo de Estudio para las Hepatopatías Asociadas a Medicamentos, Geham).
18. Lucena M.I., García-Cortés M., Cueto R., López-Durán J., Andrade R.J. Assessment of drug-induced liver injury in clinical practice. Fundam Clin Pharmacol 2008, 22:141-158.